Overview

Pharmacokinetics of Sirolimus and Tacrolimus in Liver Transplant Recipients With Tacrolimus Toxicity

Status:
Terminated
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
Pharmacokinetics of Tacrolimus and Sirolimus alone and in combination in liver transplant recipients.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
University of Pittsburgh
Treatments:
Everolimus
Sirolimus
Tacrolimus